bispecific antibodies, page-2

PoS -

A Bispecific Antibody is basically what Genetech engineered to cross the blood-brain barrier.

In other recent studies peptides often act in the second arm of similar structures - and of course peptides are also sometimes used in generating antibodies.

Wether Phylogica is directly involved in that outcome is still a speculative presumption - but i guess it also says while not much information is out their in regards to Phylogicas work in bispecific antibodies it could well play a role.


Here's a piece from Genetech in commenting on them after BBB -

"We're about to see a wave of bispecific antibodies," says Ryan Watts, a neurobiologist at Genentech, a biotechnology firm based in San Francisco, California, that pioneered the development of therapeutic antibodies and is now a division of the Swiss pharmaceutical giant, Roche. "They are the hot topic in the field."